among other prognostic factors. Median follow-up was 31 months for patients 65 years and 16 months for patients >65 years (Fig2). Conclusion: Daily low-dose cisplatin and high dose radiotherapy in stage III NSCLC is as tolerable for both young and older patients resulting in similar toxicity and overall survival.
Background: After pulmonary resections, one or two chest tubes are used, and the choice is based mainly on local habits rather than on evidence. The aim of the study was to evaluate the impact of quantitatively assessed emphysema on chest drainage using one or two tubes in patients with non-small cell lung cancer (NSCLC). Method: Single-centre, prospective randomized trial including patients who underwent lobectomy for NSCLC between February 2016 and December 2017. At the end of the operation, patients were randomized in a 1:1 ratio to the single tube group or to the two tubes group. On the day of surgery, controlled suction of -20 cm H2O was used, switched on the 1st postoperative day to -8 cm H2O. Amount and duration of air leak, chest tube output and differential pleural pressure were recorded using digital chest drainage system. Prolonged air leak was defined as leak lasting >72 h. Chest tubes were removed in the absence of air leak for more than 24 hours, and the chest tube output <250 mL/day. Quantitative analysis of emphysema was performed using the syngo CT. 3D Pulmo software. Result: There were 160 patients enrolled, including 100 men, mean age 65.15 years (range: 32-83) and 60 women, mean age 64.58 years (range: 24-81). One chest tube was used in 82 patients, including 52 cases of VATS lobectomy and 108 cases of open lobectomy. Two chest tubes were used in 78 patients, including 22 patients after VATS lobectomy and 56 after open lobectomy. Quantitative assessment of emphysema was performed in a CT study in 160 patients via an assessment evaluation index. In the single chest tube group there was significantly less air leak in first six hours (124.26 vs. 257.1mL/ min; p ¼ 0.01),volume of chest tube output (241.08 vs 345.82 mL; p ¼ 0.000015), and differential in first six hours pleural pressure (2.55 vs 3.14 cm H20); p ¼ 0.041. Multivariate regression analysis has shown significant effect of lung volume (dV) (p ¼ 0.007) and mean lung density (dMLD) (p ¼ 0.012) for prolonged air leak in the single chest tube group. In two chest tube group, a significant impact of lung volume (p ¼ 0.002) on the volume of chest tube output was found. Conclusion: Emphysema and lung volume affect the prolonged air leak following lung resection. Background: Lung cancer is a highly immune-suppressing malignancy with numerous methods to evade antitumor immune responses, including deficiencies in antigen processing and presentation, release of immunomodulatory cytokines, and inhibition of T cell activation. Our previous research also demonstrate that radiation can induce a local inflammatory response and simultaneously induce programmed death ligand 1 (PD-L1) expression that attenuate the sensitivity of radiation response in NSCLC. Current data have implicated that the molecular mechanisms by which DHA functions as radiosensitizer are varied, such as inducing apoptosis, extracellular signal-regulated protein kinases 1/2 (Erk1/2) activity, nuclear factor-kappa-B (NF-ƘB), and so on. However, there is no research about the immunity system alterations after the treatment of DHA plus radiation.In the present study, we demonstrate that combined DHA and radiotherapy synergistically enhances the anti-tumor effect by inhibiting the expression of PD-L1, eradicating the local accumulation of tumorinfiltrating regulatory T cells (iTregs) and myeloid-derived suppressor cells (MDSCs) and stimulating CD8+ T cell infiltration in the tumor microenvironment. Furthermore, DHA may also through inhibiting TGF-b, p-AKT and p-STAT3 pathways, epithelial-mesenchymal transition (EMT) process, facilitating apoptosis, and regulating TRIM21 to induce the synergistic anti-tumor effect. Method: Radiation resistance cell lines (A549/X) was induced from A549 by conventionally fractionated radiation. The relationship between PD-L1 expression and the radiation resistance and the immune cell was investigated by immunohistochemistry (IHC) and western blot in vitro and vivo. Apoptosis was evaluated by flow cytometry. The signaling pathway proteins, epithelial-mesenchymal transition
